J Martel-Pelletier1, J P Pelletier, J M Cloutier
1Unité des Maladies Rhumatismales, Hôpital Notre-Dame, Université de Montréal, Canada.
Rheumatoid arthritis (RA) cartilage proteoglycans (PGs) show structural differences based on patient therapy. Metalloprotease activity, influenced by treatments like prednisone and DMARDs, alters PG structure and aggregation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: